PUBLISHER: SPER Market Research Pvt. Ltd. | PRODUCT CODE: 1749638
PUBLISHER: SPER Market Research Pvt. Ltd. | PRODUCT CODE: 1749638
Anti-acne Cosmetics Market Introduction and Overview
According to SPER market research, 'Global Anti-acne Cosmetics Market Size- By Product Type, By Gender, By End-User - Regional Outlook, Competitive Strategies and Segment Forecast to 2034' state that the Global Anti-acne Cosmetics Market is predicted to reach 14.12 billion by 2034 with a CAGR of 9.63%.
There are several skincare solutions on the market that are specifically made to address acne issues in both men and women. A prevalent dermatological condition, acne can affect one's self-confidence and lead to social stigma. Face cleansers, moisturisers, emulsions, and spot therapy treatments are examples of anti-acne cosmetics. These cosmetic products are sold in a variety of establishments, including retail stores, dermatology clinics, med spas, and beauty salons.
Restraints: Specialised acne treatment treatments are expensive, which is one of the main factors preventing the global market for anti-acne cosmetics from expanding. The need for tailored skincare solutions is becoming more and more apparent to customers, yet many high-end anti-acne cosmetics are expensive, particularly those with cutting-edge or scientifically supported components.
Scope of the report:
Report Metric Details
Market size available for years 2021-2034
Base year considered 2024
Forecast period 2025-2034
Segments covered By Product Type, By Gender, By End-User
Regions covered
North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa
Companies Covered
PCA Skin (CP Skin Health Group, Inc), Obagi Cosmeceuticals LLC, Phytomer, AbbVie, skinbetter science, Colorescience, Inc, Sente Inc, JMSR, Inc, Revision Skincare, Beauty Health, Glowbiotics, Perricone MD.
Global Anti-acne Cosmetics Market Segmentation:
By Product Type: Based on the Product Type, Global Anti-acne Cosmetics Market is segmented as; Mask, Creams & Lotions, Cleansers & Toners, Others.
By Gender: Based on the Gender, Global Anti-acne Cosmetics Market is segmented as; Women, Men.
By End User: Based on the End User, Global Anti-acne Cosmetics Market is segmented as; Dermatology Clinics, Medspa.
By Region: This research also includes data for North America, Latin America, Asia-Pacific, Europe, Middle East & Africa.
1.1. Scope of the report
1.2. Market segment analysis
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPER's internal database
2.1.4. Premium insight from KOL's
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTER's Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6.1. Global Anti-acne Cosmetics Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Anti-acne Cosmetics Market
7.1. Mask
7.2. Creams & Lotions
7.3. Cleansers & Toners
7.4. Others
8.1. Women
8.2. Men
9.1. Dermatology Clinics
9.2. Medspa
10.1. Global Anti-acne Cosmetics Market Size and Market Share
11.1. Asia-Pacific
11.1.1. Australia
11.1.2. China
11.1.3. India
11.1.4. Japan
11.1.5. South Korea
11.1.6. Rest of Asia-Pacific
11.2. Europe
11.2.1. France
11.2.2. Germany
11.2.3. Italy
11.2.4. Spain
11.2.5. United Kingdom
11.2.6. Rest of Europe
11.3. Middle East and Africa
11.3.1. Kingdom of Saudi Arabia
11.3.2. United Arab Emirates
11.3.3. Qatar
11.3.4. South Africa
11.3.5. Egypt
11.3.6. Morocco
11.3.7. Nigeria
11.3.8. Rest of Middle-East and Africa
11.4. North America
11.4.1. Canada
11.4.2. Mexico
11.4.3. United States
11.5. Latin America
11.5.1. Argentina
11.5.2. Brazil
11.5.3. Rest of Latin America
12.1. PCA Skin (CP Skin Health Group, Inc.)
12.1.1. Company details
12.1.2. Financial outlook
12.1.3. Product summary
12.1.4. Recent developments
12.2. Obagi Cosmeceuticals LLC
12.2.1. Company details
12.2.2. Financial outlook
12.2.3. Product summary
12.2.4. Recent developments
12.3. Phytomer
12.3.1. Company details
12.3.2. Financial outlook
12.3.3. Product summary
12.3.4. Recent developments
12.4. AbbVie
12.4.1. Company details
12.4.2. Financial outlook
12.4.3. Product summary
12.4.4. Recent developments
12.5. skinbetter science
12.5.1. Company details
12.5.2. Financial outlook
12.5.3. Product summary
12.5.4. Recent developments
12.6. Colorescience, Inc
12.6.1. Company details
12.6.2. Financial outlook
12.6.3. Product summary
12.6.4. Recent developments
12.7. Sente Inc
12.7.1. Company details
12.7.2. Financial outlook
12.7.3. Product summary
12.7.4. Recent developments
12.8. JMSR, Inc
12.8.1. Company details
12.8.2. Financial outlook
12.8.3. Product summary
12.8.4. Recent developments
12.9. Revision Skincare
12.9.1. Company details
12.9.2. Financial outlook
12.9.3. Product summary
12.9.4. Recent developments
12.10. Beauty Health
12.10.1. Company details
12.10.2. Financial outlook
12.10.3. Product summary
12.10.4. Recent developments
12.11. Glowbiotics
12.11.1. Company details
12.11.2. Financial outlook
12.11.3. Product summary
12.11.4. Recent developments
12.12. Perricone MD
12.12.1. Company details
12.12.2. Financial outlook
12.12.3. Product summary
12.12.4. Recent developments
12.13. Others